CHIP regulates AKT/FoxO/Bim signaling in MCF7 and MCF10A cells

Yanrong Lv1, Shanshan Song2, Kai Zhang1

  • 1Department of Breast Surgery, QiLu Hospital of Shandong University, Jinan, Shandong, China.

Plos One
|December 31, 2013
PubMed

Insights

Overexpression of C-terminus of Hsc70-interacting protein (CHIP) promotes cancer cell survival by disrupting the AKT/FoxO/Bim pathway, leading to apoptosis resistance. This mechanism involves regulating PTEN levels in breast cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Apoptosis resistance is a hallmark of many human cancers, yet its underlying mechanisms are not fully understood.
  • The C-terminus of Hsc70-interacting protein (CHIP) has been implicated in various cellular processes, but its role in apoptosis resistance requires further elucidation.

Purpose of the Study:

  • To investigate the role of CHIP overexpression in inducing apoptosis resistance.
  • To elucidate the molecular mechanisms by which CHIP regulates apoptosis resistance, focusing on the AKT/FoxO/Bim signaling pathway.

Main Methods:

  • Utilized breast cancer (MCF7) and non-tumorigenic (MCF10A) cell lines to study CHIP overexpression.
  • Investigated the effects of CHIP on AKT, Forkhead box O (FoxO) transcription factors (FoxO1, FoxO3, FoxO4), Bim, and PTEN.
  • Employed PI3K inhibition to assess the critical signaling events in CHIP-induced apoptosis resistance.
  • Examined CHIP's role in regulating PTEN at both transcriptional and post-translational levels.
  • Corroborated findings in human breast cancer tissues.

Main Results:

  • CHIP overexpression activated AKT and inhibited FoxO transcription factors (FoxO1, FoxO3, FoxO4) in MCF7 and MCF10A cells.
  • CHIP overexpression led to the inhibition of Bim and PTEN transcription.
  • Inhibition of PI3K confirmed its critical role in CHIP-induced apoptosis resistance.
  • CHIP-mediated inhibition of FoxO3 resulted in decreased PTEN levels and further activation of the AKT survival pathway.
  • Findings were validated in clinical breast cancer samples.

Conclusions:

  • CHIP overexpression induces apoptosis resistance in breast cancer cells by modulating the AKT/FoxO/Bim signaling pathway.
  • CHIP regulates PTEN protein levels through both transcriptional and post-translational mechanisms, contributing to apoptosis resistance.
  • The CHIP-AKT/FoxO/Bim axis represents a potential therapeutic target for overcoming apoptosis resistance in cancer.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K